troglitazone has been researched along with HIV Coinfection in 1 studies
Troglitazone: A chroman and thiazolidinedione derivative that acts as a PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS (PPAR) agonist. It was formerly used in the treatment of TYPE 2 DIABETES MELLITUS, but has been withdrawn due to hepatotoxicity.
Excerpt | Relevance | Reference |
---|---|---|
"Treatment with troglitazone 400 mg q." | 6.69 | Effects of troglitazone on insulin sensitivity in HIV-infected patients with protease inhibitor-associated diabetes mellitus. ( Brinkmann, L; Goebel, FD; Michl, GM; Mühlbayer, D; Walli, R, 2000) |
"Treatment with troglitazone 400 mg q." | 2.69 | Effects of troglitazone on insulin sensitivity in HIV-infected patients with protease inhibitor-associated diabetes mellitus. ( Brinkmann, L; Goebel, FD; Michl, GM; Mühlbayer, D; Walli, R, 2000) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Walli, R | 1 |
Michl, GM | 1 |
Mühlbayer, D | 1 |
Brinkmann, L | 1 |
Goebel, FD | 1 |
1 trial available for troglitazone and HIV Coinfection
Article | Year |
---|---|
Effects of troglitazone on insulin sensitivity in HIV-infected patients with protease inhibitor-associated diabetes mellitus.
Topics: Adipose Tissue; Adult; Anti-HIV Agents; Blood Glucose; Body Weight; Chromans; Diabetes Mellitus; HIV | 2000 |